featured
The Growing Burden of Invasive Melanoma
abstract
This abstract is available on the publisher's site.
Access this abstract now Full Text Available for ClinicalKey Subscribers
New melanoma therapies are being developed rapidly, complementing prevention and detection strategies for disease control. Estimating the future burden of melanoma is necessary for deciding how best to deploy limited resources to achieve this goal. Using three decades of cancer registry data (1982-2011) from six populations with moderate-to-high melanoma incidence (US Whites, United Kingdom (UK), Sweden, Norway, Australia, New Zealand), we applied age-period-cohort models to describe current trends and project future incidence rates and numbers of melanomas out to 2031. Between 1982-2011, melanoma rates in US Whites, UK, Sweden and Norway increased at >3% annually and are projected to continue rising until at least 2022. Melanoma incidence in Australia has been declining since 2005 (-0.7% p.a.), while melanoma incidence in New Zealand is increasing but projected to decline soon. The numbers of new melanoma cases will rise in all six populations due to aging populations and high age-specific rates in the elderly. In US Whites, annual new cases will rise from around 70,000 in 2007-11 to 116,000 in 2026-31 (79% attributable to rising age-specific rates, 21% to population growth and aging). The continued increases in case numbers in all six populations out to 2031 will increase the challenges for melanoma control.
Topic Alerts
Click on any of these tags to subscribe to Topic Alerts. Once subscribed, you can get a single, daily email any time PracticeUpdate publishes content on the topics that interest you.
Visit your Preferences and Settings section to Manage All Topic Alerts
Additional Info
Journal of Investigative Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
The Growing Burden of Invasive Melanoma: Projections of Incidence Rates and Numbers of New Cases in Six Susceptible Populations to 2031
J Invest Dermatol 2016 Feb 19;[EPub Ahead of Print], DC Whiteman, AC Green, CM OlsenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.